| Value | ₹250.0 Cr |
|---|
BSE filing, NSE: KOLTEPATIL. Summary written from the filing by ALFA Finder's alert engine.
Kolte-Patil Developers Ltd: key numbers
- Share price
- ₹466.15
- Market cap
- ₹4,134 Cr
- Revenue (annual)
- ₹735.0 Cr
- Net profit (annual)
- ₹-38.67 Cr
- P/E (TTM)
- 33.2×Sector 34.5×
- Promoter holding
- 73.81%+0.00% QoQ
- FII holding
- 11.27%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kolte-Patil Developers Ltd
All →Kolte-Patil Developers Other Announcement
Kolte-Patil Developers filed CARE Ratings' monitoring report on preferential issue proceeds for the quarter ended 30 September 2026. The report records no deviation from the offer objects.
Kolte-Patil Developers Board Meeting Date
Kolte-Patil Developers intimated a board meeting on November 3, 2026 to consider unaudited standalone and consolidated results for Q2 and half-year ended September 30, 2026. The notice is advance intimation with agenda proposed only.
Kolte-Patil Developers Price Movement Clarification
Kolte-Patil responded to an NSE surveillance query on a volume spurt, stating no material event or undisclosed information. The company is unaware of any development behind the trading increase.
Kolte-Patil Developers Other Announcement
The company submitted its quarterly shareholding pattern for the period ended September 30, 2026. This filing is a routine regulatory compliance disclosure.
Kolte-Patil Developers Business Update
Kolte-Patil Developers reported record quarterly sales of Rs. 1,019 crore for Q2 FY27 and signed six new redevelopment projects in Mumbai worth Rs. 6,000 crore GDV.
- Value
- ₹6,000 Cr
Kolte-Patil Developers Business Update
Kolte-Patil Developers achieved record sales of over Rs. 600 crore within 60 hours at its 'Vyana at The Reserve' project in Pune.
- Value
- ₹600.0 Cr
- saleable area
- 5.0 million sq ft
Other credit rating announcements
All →Epigral Credit Rating
CRISIL revised Epigral's ratings to CRISIL AA/Stable (long-term) and CRISIL A1+ (short-term) on its bank facilities. The action covers Rs.1,050 Crore of rated bank loan facilities.
Mankind Pharma Credit Rating
CRISIL reaffirmed Mankind Pharma's AA+ rating on Rs.2,500 Crore of NCDs and withdrew ratings on Rs.2,500 Crore NCDs and Rs.1,500 Crore commercial paper. The rating action is dated October 29, 2026.
Lloyds Metals & Energy Credit Rating
Crisil Ratings reaffirmed Lloyds Metals' bank facilities at AA/Stable and A1+, with bank limits enhanced to ₹17,112 crore. It assigned AA/Stable to ₹2,400 crore and ₹1,550 crore of NCDs.
Ram Ratna Wires Credit Rating
CARE Ratings assigned and reaffirmed Ram Ratna Wires' bank facility ratings at CARE A-; Positive / CARE A2+ and revised outlook from Stable to Positive. The long-term bank facilities total Rs.1,046.45 Crore, with several facilities enhanced.
Adani Ports & Special Economic Zone Credit Rating
Fitch Ratings affirmed Adani Ports' Long-Term Foreign-Currency IDR and unsecured notes at 'BBB-' with a Stable outlook. The affirmation keeps the existing rating unchanged.
Capri Global Capital Credit Rating
India Ratings affirmed CGCL's credit rating at IND AA- with Positive outlook. A new Rs. 500 Cr bank loan facility was also assigned the same rating.